Commentary Open Access
Volume 4 | Issue 4 | DOI: https://doi.org/10.33696/immunology.4.141
CAR Therapy for T-cell Malignancies
Andrew Cinquina1, Jia Feng2, Hongyu Zhang2, Yupo Ma1,*
- 1iCell Gene Therapeutics LLC, Research & Development Division, Long Island High Technology Incubator, 25 Health Sciences Drive, Stony Brook, NY 11790, USA
- 2Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, P.R. China
Corresponding Author
Yupo Ma, yupo.ma@icellgene.com
Received Date: March 14, 2022
Accepted Date: July 21, 2022
Citation:
Cinquina A, Feng J, Zhang H, Ma Y. CAR Therapy for T-Cell Malignancies. J Cell Immunol. 2022;4(4):131-133.
Copyright: © 2022 Cinquina A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.